[Progress in therapy of Parkinsonian syndrome].
D000547:Amantadine / Q000627:therapeutic use; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use; D010276:Parasympatholytics / Q000009:adverse effects / Q000627:therapeutic use; D010302:Parkinson Disease, Secondary / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D011182:Postoperative Care; D013238:Stereotaxic Techniques; D013566:Sympathomimetics / Q000009:adverse effects / Q000627:therapeutic use
D010276:Parasympatholytics; D013566:Sympathomimetics; D007980:Levodopa; D000547:Amantadine; D002262:Carboxy-Lyases
Fortschritte in der Therapie des Parkinson-Syndroms